Marinomed Biotech AG: Change of total number of voting rights and capital according to article 135 section 1 BörseG

Korneuburg (pta007/31.01.2024/10:00 UTC+1)

Marinomed Biotech AG hereby announces that due to the exercise of the convertible bond with Nice & Green the total number of voting rights at the end of January 2024 has increased to 1,529,116 and the Company's new share capital amounts to EUR 1,529,116. The change of total voting rights has been effective since January 8, 2024.

(end)

Emitter:	Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria
Contact Person:	Pascal Schmidt, CFO
Phone:	+43 2262 90300
E-Mail:	pascal.schmidt@marinomed.com
Website:	www.marinomed.com
ISIN(s):	ATMARINOMED6 (Share)
Stock Exchange(s):	Vienna Stock Exchange (Official Trade)